|
| |
Abstract |
|---|
|
|
|---|
Inflammation of the respiratory tract is associated with the production of reactive oxygen species, such as
hydrogen peroxide (H2O2) and superoxide (O2
), which contribute extensively to lung injury in diseases of the respiratory tract. The mechanisms and target molecules of these oxidants are mainly unknown but may
involve modifications of growth-factor receptors. We have shown that H2O2 induces epidermal growth
factor (EGF)-receptor tyrosine phosphorylation in intact cells as well as in membranes of A549 lung epithelial cells. On the whole, total phosphorylation of the EGF receptor induced by H2O2 was lower than that
induced by the ligand EGF. Phosphorylation was confined to tyrosine residues and was inhibited by addition of genistein, indicating that it was due to the activation of protein tyrosine kinase (PTK). Phosphoamino acid analysis revealed that although the ligand, EGF, enhanced the phosphorylation of serine, threonine, and tyrosine residues, H2O2 preferentially enhanced tyrosine phosphorylation of the EGF receptor.
Serine and threonine phosphorylation did not occur, and the turnover rate of the EGF receptor was slower
after H2O2 exposure. Selective H2O2-mediated phosphorylation of tyrosine residues on the EGF receptor
was sufficient to activate phosphorylation of an SH2-group-bearing substrate, phospholipase C-
(PLC-
),
but did not increase mitogen-activated protein (MAP) kinase activity. Moreover, H2O2 exposure decreased protein kinase C (PKC)-
activity by causing translocation of PKC-
from the membrane to the cytoplasm. These studies provide novel insights into the capacity of a reactive oxidant, such as H2O2, to modulate EGF-receptor function and its downstream signaling. The H2O2-induced increase in tyrosine phosphorylation of the EGF receptor, and the receptor's slower rate of turnover and altered downstream
phosphorylation signals may represent a mechanism by which EGF-receptor signaling can be modulated
during inflammatory processes, thereby affecting cell proliferation and thus having implications in wound
repair or tumor formation.
| |
Introduction |
|---|
|
|
|---|
Inflammatory diseases of the respiratory tract, such as
asthma, bronchiectasis, and adult respiratory distress syndrome (ARDS), are characterized by a large increase in
inflammatory oxidants, such as hydrogen peroxide (H2O2)
and superoxide (O2
). These reactive oxidants play a major role in lung injury, characterized by increased epithelial cell permeability and decreased lung function. The
mechanisms and target molecules of these oxidants are
mainly unknown but may involve modification of growth-factor receptors. It is crucial that we understand how signaling pathways relate to oxidant-generating systems, the
nature and regulation of the enzymes involved, and the
consequences of these enzymes' modification during episodes of stress.
Aerobic cells are constantly exposed to reactive oxygen
intermediates (ROIs), which are generated under various
physiologic and pathologic conditions, such as inflammation, reperfusion, sepsis, and irradiation (1). Increased intracellular levels of the ROIs O2
, hydroxyl radical (·OH),
or H2O2 are referred to as oxidative stress. Free radicals
and redox stress induced by an excess of ROIs have been
shown to play important roles in carcinogenesis by directly
damaging DNA and acting as tumor promoters (2). Because induced intracellular ROI levels are now thought to
participate in cellular signaling (6), additional targets
for ROIs may exist. Indeed, exposure of cells to H2O2 activates the transcription factors c-jun (11, 12) and nuclear
factor-
B (NF-
B) (6, 13), stimulates mitogen-activated
protein (MAP) kinase activity (14), and induces transcription of human immunodeficiency virus (HIV) (15). The
observation that H2O2 can induce rapid tyrosine phosphorylation of multiple cellular proteins (16) suggests that
ROIs can regulate protein tyrosine kinases (PTKs) and
protein tyrosine phosphatases.
One group of proteins that may be importantly affected
by inflammatory oxidants are membrane receptors for
various growth factors or cytokines that are induced and
activated during inflammation to promote wound-healing
processes. Among these receptors is the epidermal growth
factor (EGF) receptor, which is overexpressed and activated in response to epithelial injury, and which functions in epithelial repair (20). The EGF receptor is a
member of the receptor tyrosine kinase superfamily and
is involved in regulating the proliferation and differentiation primarily of epithelial cell types (23, 24). The EGF
receptor is a 170-kD glycoprotein (25) that spans the
membrane via one
-helical segment of 23 amino acids,
connecting a large, heavily glycosylated extracellular ligand-binding domain and an intracellular tyrosine kinase domain.
Activation of the EGF receptor occurs in the following
stages: Binding of EGF or transforming growth factor-
(TGF-
) to individual EGF receptors stimulates formation of noncovalent dimeric (or oligomeric) structures involving two (or more) receptors. The enzymatic tyrosine
kinase activity of one receptor transphosphorylates residues on the opposite member of the receptor pair or
dimer. Once activated, the receptor initiates a series of signal-transduction events through the tyrosine phosphorylation of interacting proteins that belong to the SH2 family,
resulting in a sequence of responses that are involved in
the mitogenic signal-transduction pathways of cells, ultimately leading to stimulation of DNA replication and cell
division (25, 27). Besides undergoing tyrosine phosphorylation, the EGF-activated receptors are phosphorylated in vivo on serine/threonine, a mechanism by which
receptor functions are attenuated. Various cellular protein
kinases, such as protein kinase C (PKC), MAP kinase,
p34cdk2 kinase, and casein kinase II, are considered to be
involved in this serine/threonine phosphorylation and receptor attenuation (33). As a final step, the activated
EGF receptor/ligand complex is internalized and is eventually degraded in lysosomes or dissociated for EGF-receptor recycling.
Recently, the signaling mechanism of the EGF receptor
has been shown to involve generation of H2O2 (37), and
various reports have indicated that oxidative modification
of a reduced cysteine residue in the EGF receptor may reversibly affect its activation (38). Thus, despite the lack
of evidence for a specific receptor for O2
or H2O2 (41),
these molecules may nonetheless interact with the EGF
receptor. We have previously shown that the EGF receptor mediates resistance to ionizing radiation in A431 cells
by enhancing its tyrosine phosphorylation (42, 43). Other
investigators have suggested that cellular effects of ionizing radiation and ultraviolet radiation may be mediated
by ROIs (44, 13). Therefore, we designed studies to explore whether the EGF receptor is a more general target
for reactive radicals and may therefore sense cellular redox status.
In experiments designed to investigate how the function of the EGF receptor is affected by H2O2, we measured receptor phosphorylation in growing cells, in isolated membranes, and in purified EGF receptor exposed
to H2O2. Our findings show that H2O2 stimulates EGF-
receptor tyrosine phosphorylation. In all situations, phosphorylation was restricted to tyrosine residues. Serine and
threonine residues of the EGF receptor were not phosphorylated, and the half-life of the receptor was longer after H2O2 exposure. At the same time, phospholipase C-
(PLC-
), but not MAP kinase, was activated by H2O2,
whereas PKC-
was deactivated by its translocation to the cytoplasm.
| |
Materials and Methods |
|---|
|
|
|---|
Materials
EGF was obtained from Collaborative Research (Waltham,
MA), [35S]methionine, [32P]orthophosphate, [methyl-3H]thymidine, and 125I-labeled protein A were from DuPont-New
England Nuclear. Antiphosphotyrosine antibody PY69 and
genistein were purchased from ICN Biochemical Inc. (Cleveland, OH). Antiphosphotyrosine antibody PY20 and anti-MAP kinase antibody were purchased from UBI Inc.
(Santa Cruz, CA). Antiphosphotyrosine Ab-1-agarose conjugate was from Oncogene Science (Manhasset, NY). Polyclonal antiphospholipase C-
antibody was from Upstate
Biotechnology Inc. (Lake Placid, NY). Monoclonal anti-EGF receptor antibodies 528 and LA22 were kindly provided by Dr. J. Mendelsohn (Memorial Sloan Kettering
Cancer Center, New York, NY) and Dr. J. D. Sato (Alton
Jones Center, Lake Placid, NY), respectively. Antiserum
RK2 to the EGF receptor carboxyl-terminal peptide was
kindly provided by Dr. J. Schlessinger (New York University Medical Center, New York, NY). All of the other
chemicals were from Sigma Chemical Co. (St. Louis, MO)
unless otherwise indicated.
Cell Culture and Treatments
A549 cells (derived from lung adenocarcinoma) were obtained from the American Type Culture Collection (Rockville, MD) and were grown in monolayer culture in Ham's F-12 medium containing 10% fetal bovine serum (FBS) (both from GIBCO Laboratories, Grand Island, NY). For individual experiments, A549 cells were seeded into six-well plates in appropriate medium supplemented with 10% FBS, and were switched to 1% FBS on the following day. Freshly made 10 mM H2O2 solution was added to the medium to the final desired concentrations 12 h later. After incubation at 37°C for the indicated times, the medium was aspirated and the cells were washed with ice-cold phosphate-buffered saline (PBS), pH 7.4.
Cell Proliferation: Rate of DNA Synthesis as Measured by Thymidine Incorporation
Cells were cultured as described previously and were treated with EGF or H2O2 for 24 h. During the last 6 h of treatment, 1 mCi/ml of [methyl-3H]thymidine was present in the culture media. At the end of the labeling period, cells were washed in ice-cold PBS and then in 10% ice-cold trichloroacetic acid (TCA). The acid-insoluble material was washed twice in 10% TCA. The incorporated radioactivity was measured by scintillation counting (45).
Cell-Cycle Analysis
After treatments, cells were harvested by trypsinization, pelleted, and gently resuspended in PBS. These cells were held on ice until they could be lysed and the nuclei could be stained. The percentage of cells in different phases of the cell cycle was determined with flow cytometry (46). Briefly, cells were stained with propidium iodide (Sigma) and passed through the beam of an argon-ion laser tuned to 514 (FACScan; Becton Dickinson, Moutain View, CA). The resulting fluorescence signal was amplified, recorded in the instrument's memory, and analyzed in the form of a DNA histogram by using a computer program interfaced with the integrator.
Western Blot Analysis of Phosphotyrosines, EGF
Receptors, PLC-
, and MAP Kinase
After exposure to H2O2, cells were cultured for the indicated times in the presence or absence of EGF, followed
by removal of the culture medium and by rinsing of the
cells with cold PBS. Cells were lysed in a lysis buffer containing a mild detergent and protease and phosphatase inhibitors (50 mM N-2-hydroxyethylpiperazine-N'-ethane sulfonic acid [Hepes], pH 7.5; 1% Triton X-100; 10% glycerol; 1 mM phenylmethylsulfonyl fluoride (PMSF); 10 µg/
ml leupeptin; 10 µg/ml aprotinin; 2 mM sodium orthovanadate (Na3VO4); 1.5 mM magnesium chloride (MgCl2);
1 mM ethyleneglycol-bis-(
-aminoethyl ether)-N,N,N',N'-tetraacetic acid [EGTA]), and were incubated for 30 min
at 4°C. The lysates were then mixed with concentrated sodium dodecyl sulfate (SDS) sample buffer to achieve final
concentrations of 62.5 nM Tris-HCl, pH 6.8; 2% SDS;
0.5% 2-mercaptoethanol; and 10% glycerol, and were
boiled for 5 min. Samples were analyzed with 7% SDS-
polyacrylamide gel electrophoresis (PAGE) and were western blotted, and nitrocellulose membranes were incubated
with antiphosphotyrosine monoclonal antibody (mAb)
PY69 or PY20 (at concentrations of 4 µg/ml), with anti-EGF receptor peptide polyclonal antibody RK2, with anti-EGF receptor mAb LA22 (at a concentration of 1 µg/ml),
with anti-PLC-
polyclonal antibody, or with anti-MAP kinase mAb. Bound antibody was detected with 125I-protein A, or with a peroxidase-conjugated second antibody
and chemiluminescence (ECL kit from Amersham, Arlington Heights, IL) (45). Sample protein concentrations
were equalized before loading onto the gels. Either whole
lysates or the immunoprecipitated (with 528 mAb) EGF
receptor (see the subsequent discussion) were transferred
onto the membrane and incubated with antiphosphotyrosine antibody (either mAb PY69 or mAb PY20). For the determination of PLC-
phosphorylation, either whole lysate or
immunoprecipitated phosphotyrosine proteins (with antiphosphotyrosine Ab-1-agarose conjugate; see the subsequent discussion) were transferred onto the membrane
and incubated with polyclonal anti-PLC-
antibody. For
the determination of tyrosine phosphorylation of MAP kinase, we also used immunoprecipitation with an antiphosphotyrosine antibody followed by Western blot analysis
with an anti-MAP kinase mAb to show that the tyrosine-phosphorylated protein bands at 42 and 45 molecular
weight correspond to activated MAP kinase (49). Unless
indicated otherwise, data shown for all Western blots are representative of at least three experiments.
Cell Metabolic Labeling
Cells were plated in 10% FBS culture medium for 2 d to reach approximately 70% confluence. For [35S]methionine labeling, cells were switched to the labeling medium (90% methionine-free culture medium, 10% regular medium, 100 µCi of [35S]methionine/ml, and 1% dialyzed FBS) for 16 h. After removing the labeling medium, the cells were rinsed twice with fresh medium and cultures were chased in 1% dialyzed FBS medium for varying periods in the presence or absence of EGF or H2O2. For [32P]orthophosphate labeling, cells were grown for 16 h in phosphate-free medium with the addition of 300 µCi of [32P]orthophosphate/ml, 4 mM glutamine, 1 mM sodium pyruvate, and 1% dialyzed FBS. Cells were incubated with H2O2 or with EGF during the final 30 min of labeling (45). After incubation for the indicated times, cells were rinsed with cold PBS, incubated in Triton X-100 lysis buffer, and subjected to EGF receptor immunoprecipitation as described subsequently.
Immunoprecipitation
Cells in Triton X-100 lysis buffer were incubated for 30 min in an orbital shaker at 4°C. To remove insoluble material, cell lysates were centrifuged at 14,000 rpm for 5 min at 4°C, and supernatants were precleared by adding 50 µl of 20% pansorbin (Calbiochem) to each sample and incubating for 1 h at 4°C. Aliquots of supernatants containing equal amounts of protein were immunoprecipitated for 2 h at 4°C with either anti-EGF receptor mAb 528/rabbit antimouse IgG (Accurate Chemical & Scientific Corp.)/protein A-Sepharose (Pharmacia LKB Biotechnology, Inc.) conjugate or with antiphosphotyrosine Ab-1 agarose conjugate (45).
In Vitro Membrane Phosphorylation
Membrane fractions were prepared and the in vitro phosphorylation assay was done as previously described (45). Briefly, cells were collected in SAT buffer (0.25 M sucrose, 10 mM acetic acid, 10 mM triethanolamine, pH 7.4) and lysed in SEAT buffer (1 mM ethylenediamine tetraacetic acid [EDTA] in SAT buffer), followed by centrifugation at 800 rpm for 5 min to pellet nuclei. The supernatant was centrifuged at 100,000 rpm for 15 min to pellet the membrane. The resulting pellet was resuspended in Hepes-Triton buffer (20 mM Hepes, pH 7.4; 1% Triton X-100; 0.2 mM EDTA; 10% glycerol) and centrifuged at 100,000 rpm for 15 min. The supernatant containing the solubilized membrane fraction was used. The reaction mixture for the in vitro phosphorylation assay (final volume: 30 µl) contained 20 mM Hepes, pH 7.4; 1 mM MnCl2; 5 µg bovine serum albumin (BSA); 5 µM adenosine triphosphate (ATP); and 10 µg membrane protein. The reaction was initiated by the addition of [32P]ATP (in a total of 5 µM ATP), incubated for 10 min, and terminated by the addition of Laemmli's sample buffer.
Analysis of Phosphoamino Acids by Two-Dimensional Electrophoresis
Two-dimensional phosphoamino acid analysis of EGF receptors labeled metabolically with [32P]orthophosphate was performed as described previously (45). Briefly, the polyacrylamide gel band containing EGF receptors was excised and homogenized. Labeled EGF receptors were precipitated with 15% TCA and partly hydrolyzed in 100 µl of 6 N HCl at 110°C for 1 h, followed by three cycles of washing with deionized water and lyophilization. The recovery of total labeled material in individual samples was 65-70%. The hydrolysate was subjected to two-dimensional thin-layer electrophoresis (TD-TLE). The radioactivity associated with individual phosphoamino acids was measured by scraping spots from the thin-layer plate and counting in a beta-counter.
Immunokinase Assay for Measuring EGF-Receptor Tyrosine Protein Kinase Activity
Cells were lysed and immunoprecipitated as described previously. Immune complexes were washed three times with 0.1% Triton X-100 in PBS (pH 7.4) and resuspended in 25 µl of 20 mM Hepes (pH 7.4)-100 µM Na3VO4-0.1% Triton X-100. EGF-receptor kinase activity assay was initiated as described (31, 45) by the addition of 25 µl of 20 mM Hepes-0.1% Triton X-100-6 mM MnCl2 buffer containing 10 µCi of [32P]ATP (in a total of 5 µM ATP) to each sample. The reaction was incubated for 10 min at 4°C, and was terminated by the addition of sample buffer. Immunokinase complexes were subjected to 7% PAGE. Gels were dried and subjected to autoradiography, and EGF receptor-autophosphorylated bands were excised and quantified by Cerenkov counting, as previously described (45).
PKC Activity
A549 cells were harvested by scraping in cold buffer A (20 mM Tris-HCl, pH 7.5; 250 mM sucrose; 6 mM EDTA; 0.5 mM dithiothreitol [DTT], supplemented with the protease inhibitors PMSF [0.5 mM], leupeptin [50 µg/ml], and aprotinin [20 µg/ml]). The cells were sonicated for 1 min in a bath sonicator and centrifuged at 500 × g for 5 min at 4°C to remove nuclei and whole cells. The cytosolic fraction was separated from the membranes by centrifugation at 100,000 × g for 1 h. Membrane-bound PKC was solubilized by resuspending the pellet in buffer A containing 0.5% Triton X-100 for 20 min on ice, and centrifuging for 30 min at 100,000 × g to remove nonsoluble material. Both the cytoplasmic and the solubilized membrane fraction were applied to a 0.2 ml DEAE-cellulose (DE-52) anion-exchange chromatography column, washed with buffer B (20 mM Tris, pH 7.5; 2 mM EDTA; and 5 mM EGTA). Bound PKC was eluted batchwise with 500 µl buffer C (buffer B containing 0.15 M NaCl). PKC activity was detected with the PKC enzyme assay kit (Amersham) according to the manufacturer's instructions and as previously described (42). 12-O-tetradecanoyl phorbol-13-acetate (TPA) was used as a positive control.
Western Blotting of PKC
PKC-containing protein fractions that were eluted from the DE-52 columns (see the previous discussion) were separated on SDS-10% PAGE and Western blotted onto nitrocellulose membranes, and the membranes were blocked in 3% BSA in PBS. PKC was detected by incubating the membrane in specific antibodies directed against the various PKC isozymes (1:1,000 in PBS). Bound antibodies were detected with protein A-conjugated horseradish peroxidase (HRP). Blots were scanned with an LKB Ultrascan XL densitometer to quantify PKC immunoreactivity, as previously described (42).
Extraction and Analysis of 1,2-Diacylglycerol
Diacylglycerol (DAG) levels were determined with the
DAG kinase assay according to Preiss and colleagues (50),
and as previously described (42, 51). Briefly, cells were
washed with cold PBS, scraped, and centrifuged, and lipids
were extracted from cell pellet with 1 ml chloroform-
methanol-HCl (100:100:1, vol/vol) and 0.3 ml of a buffered saline solution (135 mM NaCl; 4.5 mM KCl; 1.5 mM
CaCl2; 0.5 mM MgCl2; 5.6 mM glucose; 10 mM Hepes, pH
7.2; and 10 mM EDTA). The organic phase containing
DAG was evaporated. The DAG kinase assay was done as
described (50). Briefly, the evaporated lipid fractions were
resuspended in 20 µl of an octyl-
-D-glucoside/cardiolipin
solution (7.5% octyl-
-D-glucoside, 5 mM cardiolipin in
1 mM diethylenetriamine pentaacetic acid by bath sonication, followed by incubation at room temperature for 15 min. The reaction buffer was prepared as a 2× solution,
containing 100 mM imidazole HCl, pH 6.6; 100 mM NaCl;
25 mM MgCl2; and 2 mM EGTA. To the 20 µl of solubilized
lipid/octylglucoside solution, the following were added: 50 µl of the 2× reaction buffer, 2 µl of 100 mM DTT, and
DAG kinase (0.022 U). The final volume of the reaction
mixture was 100 µl. The reaction was started by the addition of 1 µl of 10 mCi/ml [
-32P]ATP, and was allowed to
proceed for 30 min at 25°C. The reaction was stopped by
the addition of chloroform-methanol-HCl (100:100:1, vol/
vol). The chloroform phase was then collected, evaporated, resuspended in 10 µl chloroform-methanol (1:1, vol/vol),
and spotted on a Silica Gel 60 thin layer chromatography
plate. The plate was developed with chloroform-methanol-acetic acid (65:15:5, vol/vol), air-dried, and autoradiographed. The spots corresponding to DAG were scanned
in a densitometer and presented as density units.
| |
Results |
|---|
|
|
|---|
A549 Cell Growth Is Modulated by H2O2
A549 cultures were examined for the effects of H2O2 and EGF on the rate of DNA synthesis and thymidine incorporation. In an epithelial tumor-cell line with increased numbers of EGF receptors, such as A549 cells, EGF can inhibit growth (43, 45, 46, 52). As expected, and as shown in Figure 1, addition of 5 nM EGF was antiproliferative for A549 cells, and reduced the rate of thymidine incorporation into DNA to 70% of control values. Exposure of cultures to H2O2 was also inhibitory to DNA synthesis and the rate of thymidine incorporation, as compared with these processes in untreated cells. The extent of H2O2- induced growth inhibition was dose dependent, and was maximized at 400 µM (50% inhibition). Moreover, when EGF-treated cultures were exposed to H2O2 (Figure 1A), the antiproliferative effects were additive, suggesting two independent effects. A simple additive response suggests a lack of interaction, in that real interactive effects would either produce synergy or antagonism.
|
|
Flow-cytometric cell-cycle analysis performed on control, H2O2-treated, and EGF-treated A549 cells demonstrated that H2O2 exposure as well as EGF treatment increased the fraction of cells in the G0-G1 phase and reduced the number of cells in the S phase of the cell cycle (Figures 1B through 1E, and Table 1). However, the most prominent effect on the cell-cycle distribution was observed upon treatment with H2O2 in the presence of EGF (Figure 1E). After only 24 h of treatment in the presence of 200 µM H2O2 plus 5 nM EGF, the S-phase contribution was reduced from 37.3% to 13.4%. In comparison, treatment with either 5 nM EGF alone or with 200 µM H2O2 reduced the S-phase contribution to 28% and 25.4%, respectively (Table 1).
EGF-Receptor Tyrosine Phosphorylation Is Modulated by H2O2
The observation of added effects of H2O2 and EGF on cell proliferation led us to search for alterations in EGF receptor function following H2O2 exposure, and to compare these changes with the effects of EGF. A series of experiments were done to determine whether exposure of cells to H2O2 results in changes in phosphorylation of the EGF receptor. First, the effects of H2O2 were examined in intact cells either with whole lysates (Figure 2) or after immunoprecipitation of the EGF receptor with anti-EGF receptor mAb 528 (Figure 3). Then, to investigate the possibility that H2O2 may directly affect phosphorylation of the EGF receptor under cell-free conditions, we studied the effects of H2O2 either on membrane preparations or on purified, immunoprecipitated receptor (Figure 4).
|
|
|
As shown in Figure 2, A549 cell cultures were exposed to 100 µM H2O2, 20 nM EGF, or both. Cells were lysed and equal amounts of total protein lysates were subjected to SDS-PAGE analysis. Paired Western blots were immunodetected either with PY20 antiphosphotyrosine antibody (Figure 2A) or with LA22 anti-EGF receptor antibody (Figure 2B). Only antiphosphotyrosine immunoblots showed changes in the intensity of the phosphorylated tyrosines of the EGF receptor (PY20 immunoblots, Figure 2A); no changes were observed in the intensity of the receptor itself (LA22 immunoblots, Figure 2B). This indicates that the amount of EGF receptor remained unchanged, whereas its tyrosine phosphorylation increased with either H2O2 or EGF treatment. In addition, Figures 2A and 2C show that 100 µM H2O2 enhanced EGF-receptor tyrosine phosphorylation 4-fold (from 950 cpm to 3,800 cpm; Figures 2A and 2C, lane 3 versus lane 1), whereas EGF augmented tyrosine phosphorylation 5.5-fold (from 950 cpm to 5,200 cpm; Figures 2A and 2C, lane 2 versus lane 1). Moreover, H2O2 further enhanced the EGF-induced EGF-receptor tyrosine phosphorylation: as shown, EGF plus 100 µM of H2O2 raised the degree of receptor tyrosine phosphorylation 8.5-fold (from 950 cpm to 8,075 cpm; Figures 2A and 2C, lane 4 versus lane 1). This clearly demonstrates that at a saturating EGF concentration, additional tyrosine phosphorylation could be caused by H2O2.
The kinetics of H2O2-induced EGF-receptor tyrosine phosphorylation is demonstrated in Figure 2D. As shown, EGF-receptor tyrosine phosphorylation was stimulated to a level almost 4-fold that of the control after 15 min of treatment with 100 µM H2O2, and remained elevated for several hours (see Figure 5, illustrating the kinetics of tyrosine phosphorylation after exposure to 100 µM H2O2, for longer time points). This increase in tyrosine phosphorylation was also shown to be H2O2-dose dependent (Figure 2E).
|
The experiments represented by Figure 2 were repeated with similar results when Western blotting was performed with antiphosphotyrosine antibody (PY20) after the immunoprecipitation of EGF receptors with mAb 528 (Figure 3). To investigate further the mechanism of EGF-receptor tyrosine phosphorylation after H2O2 exposure, we compared the responses to EGF and to H2O2 in the presence of genistein, a known specific inhibitor of protein tyrosine kinases (55). Figure 3B shows that when A549 cells were cultured in the presence of different concentrations of genistein, dose-dependent genistein inhibition of EGF-receptor tyrosine phosphorylation was observed. Both EGF- and H2O2-induced tyrosine phosphorylation of the receptor were partially attenuated in the presence of genistein. These results provide additional evidence that H2O2-induced tyrosine phosphorylation of EGF receptor is due to PTK activation.
We also performed a cell-free, in vitro phosphorylation assay by using either membrane fractions prepared from A549 cells (Figures 4A and 4B) or immunoprecipitated receptors in an immunokinase assay (Figure 4C). An increase in EGF-receptor tyrosine phosphorylation was observed when membrane fractions were exposed to H2O2 (Figures 4A and 4B), indicating a direct effect of H2O2 on membrane components to enhance EGF-receptor tyrosine phosphorylation. Moreover, when immunoprecipitated receptors in an immunokinase assay (Figure 4C) were directly exposed to H2O2, this observation was extended. An increase in receptor phosphorylation was observed again, suggesting that H2O2 may directly affect the phosphorylation of EGF receptor tyrosine residues and thus the tyrosine kinase activity of the receptor.
Two-Dimensional Phosphoamino Acid Analysis of the H2O2-Induced Phosphorylation of EGF Receptor
As shown in Figure 6 and Table 2, exposure of A549 cells to EGF induced tyrosine phosphorylation of the EGF receptor, accompanied by an increase in phosphorylation of serine and threonine residues. This observation has previously been well documented in other cell lines (43, 45, 51, 58). Therefore, it was important to investigate the effect of H2O2 on the distribution of phosphorylation of these three phosphoamino acids in the EGF receptor. The next experiments were designed to measure H2O2-induced changes in the phosphorylation of serine, threonine, and tyrosine in EGF receptors (Figure 6). A549 cells were equilibrium-labeled with [32P]orthophosphate and then treated with 20 nM EGF for 20 min at 37°C, or exposed to 200 µM H2O2 for 20 min before being lysed. The EGF receptors were immunoprecipitated from the lysates with mAb 528 and subjected to SDS-PAGE. EGF receptor bands were cut and hydrolyzed in HCl. The amino acids were separated by TD-TLE, and 32P incorporation into tyrosine, threonine, and serine was measured (Figure 6 and Table 2). The results show that in contrast to EGF, which stimulated a marked increase in phosphorylation of tyrosine, threonine, and serine, H2O2 selectively stimulated tyrosine phosphorylation, with little effect on threonine and serine phosphorylation. The total observed increase in receptor phosphorylation was about 3-fold with EGF treatment and only about 1.6-fold with H2O2 exposure (Table 2). Thus, H2O2-induced phosphorylation of EGF receptor differs fundamentally from that induced by the ligand, EGF. Compared with phosphorylation induced by EGF, the molecular distribution among the sites of phosphorylation is shifted by H2O2 predominantly toward tyrosine phosphorylation.
|
|
EGF-Receptor Turnover Is Modulated by H2O2
Pulse/chase experiments were done to determine the effects of H2O2 and of the natural ligand, EGF, on the EGF receptor rate of turnover (Figure 7). A549 cells were prelabeled with [35S]methionine and were then cultured in fresh medium for varying intervals after the medium was supplemented with either 10 nM EGF or 100 µM H2O2. SDS-PAGE patterns of immunoprecipitated EGF receptors showed that the half-life of receptors in control cells was approximately 12 h. This fell markedly to a half-life of less than 8 h in the presence of 10 nM EGF. On the other hand, for cells cultured after being exposed to 100 µM H2O2, the half-lives were increased to 18 h (Figure 7).
|
Kinetics of EGF-Receptor and PLC-
Tyrosine
Phosphorylation by H2O2
Figure 5 shows the kinetics of EGF-receptor tyrosine
phosphorylation (Figures 5A and 5B), as well as the kinetics of PLC-
tyrosine phosphorylation (Figures 5C and
5D) in A549 lung epithelial cells cultured with 10 nM EGF
or with 100 µM H2O2 for varying intervals of up to 4 h.
The cells were lysed in Triton X-100 lysis buffer at 4°C at
each time point. The lysates were then subjected to SDS-
PAGE and immunoblotted with antiphosphotyrosine antibody PY20 (Figure 5A), with anti-EGF receptor antibody
RK2 (Figure 5B), or with anti-PLC-
antibody (Figure 5C
and 5D) after (Figure 5C) or before (Figure 5D) immunoprecipitation with antiphosphotyrosine Ab-1.
EGF-induced EGF-receptor tyrosine phosphorylation began to decline by 1 h after initiating culture with the ligand, and fell to low levels by 3 h of incubation (Figure 5A). This was expected, because of the rapid downregulation of EGF receptors caused by EGF (Figure 7), which resulted in decreased receptor levels in these cultures (Figure 5B). In contrast, induction of EGF-receptor tyrosine phosphorylation by H2O2 gradually increased with the duration of culture with H2O2, reaching peak levels at 0.25 to 0.5 h and remaining elevated for at least 4 h. The observed changes in tyrosine phosphorylation were associated with EGF receptors, since immunoprecipitation of lysates with anti-EGF receptor mAb, followed by SDS-PAGE and immunoblotting with antiphosphotyrosine antibody PY20 (as demonstrated in Figure 3), gave identical results (data not shown).
We then explored whether EGF-receptor tyrosine kinase that was activated by exposure to H2O2 could phosphorylate a substrate other than the receptor itself. PLC-
was chosen as a well-described substrate of the EGF receptor that is known to be activated by EGF (30). When
cells were cultured with EGF or H2O2 for intervals comparable with those in the previous experiment, tyrosine phosphorylation of PLC-
was also observed (Figure 5C). Following addition of EGF, the time course of phosphorylation
of PLC-
on tyrosine residues (Figure 5C) corresponded
with the kinetics of EGF-receptor tyrosine phosphorylation (Figure 5A) and degradation (Figure 5B and Figure 7), decaying after 3 h. On the other hand, the level of tyrosine-phosphorylated PLC-
increased when the duration of culture with H2O2 was extended to 4 h (whereas the
amount of total PLC-
protein was unchanged for both
H2O2 and EGF treatments [Figure 5D]). The kinetics pattern of PLC-
tyrosine phosphorylation (Figure 5C) paralleled the time course of EGF-receptor phosphorylation on
tyrosine residues in response to either EGF or H2O2 (Figure 5A). The observation that the kinetics of tyrosine phosphorylation on EGF receptors and on PLC-
were parallel
when cells were cultured with EGF (rapid elevation, followed by decay in both cases) and when cells were cultured
with H2O2 (less rapid elevation followed by much slower decay in both cases) leads to two conclusions: (1) there is a close association between the levels of EGF-receptor phosphorylation and PLC-
tyrosine phosphorylation not only
in the presence of EGF but also in the presence of H2O2;
and (2) even though PLC-
is tyrosine-phosphorylated by
H2O2, the kinetics of its tyrosine phosphorylation are completely different than those induced by EGF, which may
affect activation of PLC-
and its ability to catalyze phosphatidylinositol-2-phosphate (PIP2) hydrolysis.
PKC and MAP Kinase Modulation by H2O2
In a regular pattern of signal transduction (Figure 8), PLC-
is phosphorylated on its tyrosine residues to enhance the
catalysis of PIP2 to inositol-1,4,5-trisphosphate (IP3) and
DAG, thereby enhancing the activities of PKC and MAP
kinase (59). However, although exposure to 100 to 300 µM H2O2 increased PLC-
tyrosine phosphorylation in
parallel with raising EGF-receptor tyrosine phosphorylation (Figure 5), no increase in MAP kinase phosphorylation and activation could be observed (data not shown). At
the same time, within minutes after H2O2 exposure, PKC activity decreased 2-fold in the membrane and simultaneously
increased 2-fold in the cytosol (Figure 9A). The opposite
was observed when cells were treated with 200 nM TPA
(Figure 9B). Because PKC-
is the major isozyme in A549
cells (42), Western blot analysis demonstrated that blotted
PKC-
decreased in the membrane and increased in the
cytosol with kinetics paralleling those of the changes in PKC activity after H2O2 exposure (data not shown). The
levels of DAG, the physiologic activator of PKC-
(64),
were also decreased upon exposure of A549 cells to H2O2
(Figure 9C). Both the decrease in DAG levels (Figure 9C)
and the translocation of PKC-
from the membrane to the
cytosol (Figure 9A) occurred with the same kinetics, within
minutes after H2O2 exposure. Even though it could be expected (Figure 8) that a tyrosine-phosphorylated and thus an activated PLC-
would increase the cellular levels of
DAG, Figure 9 shows that DAG levels decreased and PKC
activity decreased as well. As shown in Figure 6, the EGF
receptor is aberrantly phosphorylated by H2O2, and transmits its downstream signal to phosphorylate PLC-
with
slower kinetics than occur with its ligand, EGF. This may
be reflected in the observed decreased levels of DAG, accompanied by translocation of PKC from the membrane
to the cytosol and no MAP kinase tyrosine phosphorylation.
|
|
| |
Discussion |
|---|
|
|
|---|
The present study provides mechanistic insights into the molecular effects of H2O2 exposure on the EGF receptor and its downstream signaling in lung epithelial cells. Cell-cycle analysis (Figure 1) suggests that both EGF and H2O2 cause G1 arrest in A549 cells. This growth arrest may be the basis of the growth inhibition observed at nanomolar to micromolar concentrations of EGF (43, 45, 46, 52, 65) and H2O2. Moreover, we have shown that H2O2 potentiates EGF-induced G1 arrest, which is again consistent with the observed additive growth-inhibitory effects of H2O2 and EGF (Figure 1). Furthermore, we suggest that these additive responses indicate a lack of interaction between the EGF- and H2O2-induced pathways, because any such interaction would have produced either synergy or contrariety.
We have shown that when lung epithelial cells are exposed to H2O2, the EGF receptor is preferentially phosphorylated on tyrosine residues (Figures 2-4, Figure 6). This is supported by similar findings in some other cells. Gamou and Shimizu showed, in the human squamous carcinoma cell line NA, that exposure to H2O2 (0.25 to 1 mM) enhanced EGF-receptor tyrosine phosphorylation. Tryptic phosphopeptide mapping of these receptors revealed that H2O2 enhanced the phosphorylation of tyrosine 1,173 and three other residues but not of serine and threonine residues (66).
The mechanism by which H2O2 activates tyrosine phosphorylation of the EGF receptor is not yet clear. EGF- receptor autophosphorylation is thought to be a trans event, involving dimerization or oligomerization followed by tyrosine phosphorylation on the opposite receptor molecule (67, 31, 32). Therefore, H2O2 could act by releasing EGF receptors from constraints that prevent their dimerization under normal physiologic conditions, such as intracellular inhibitors or structural elements attached to intact plasma membranes (68). Another possibility is that H2O2 leads to separation of critically important tyrosine phosphatases from their association with the receptor kinase. Consequently, it is possible that tyrosine phosphorylation induced by H2O2 treatment is due to activation of a kinase, inhibition of a phosphatase, or both. Treatment of A549 cells with a phosphatase inhibitor, pervanadate, induced EGF-receptor phosphorylation (data not shown), perhaps through a mechanism similar to that of oxidative stress. However, treatment of these cells with H2O2 in the presence of pervanadate enhanced the increase in tyrosine phosphorylation, suggesting that H2O2-induced tyrosine phosphorylation of the EGF receptor involves more than phosphatase inhibition, and that H2O2 treatment induces an increase in phosphorylation not only by reducing the rate of dephosphorylation.
EGF-receptor tyrosine phosphorylation induced by EGF was increased markedly when the receptor was exposed to H2O2 (Figure 2), thereby indicating that H2O2- induced tyrosine phosphorylation enhances receptor activation by the natural ligand. This clearly demonstrates that at saturating EGF concentrations, additional tyrosine phosphorylation could be caused by H2O2. Moreover, our data provide strong evidence that H2O2-induced EGF-receptor phosphorylation results from PTK activation, because the presence of genistein, a competitor of ATP binding to tyrosine kinases, can attenuate H2O2-induced tyrosine phosphorylation (Figure 3). H2O2-induced EGF-receptor tyrosine phosphorylation was reproduced in isolated membrane fractions as well as in isolated receptors in an immunokinase assay (Figure 4), suggesting that H2O2 may activate the intrinsic tyrosine kinase of the EGF receptor and phosphorylate additional tyrosine residues that are only slightly phosphorylated under physiologic conditions resulting from EGF stimulation.
Because there was no stimulation by H2O2 of receptor
serine/threonine phosphorylation, the total change in receptor phosphorylation was lower than the change observed with the ligand, EGF (Figure 6 and Table 2). The
low level of serine/threonine phosphorylation may result
in an insufficient attenuation of receptor function, such as
lack of receptor internalization. Indeed, additional observations (Figure 7) suggest that receptor turnover and
downregulation are far slower following cell exposure to
H2O2 than to EGF. This is also reflected in the kinetics of
EGF-receptor phosphorylation caused by H2O2 and the
consequent tyrosine phosphorylation of PLC-
(Figure 5).
When cells are cultured with EGF, the kinetics of PLC-
phosphorylation has a pattern of rapid elevation followed by a decay, whereas exposure to H2O2 results in a less
rapid elevation of PLC-
tyrosine phosphorylation followed by a much slower decay in the phosphorylation
(Figure 5). This difference in the kinetics pattern of phosphorylation may explain the observed interruption of the
normal flow in the downstream signaling produced by
H2O2. Normally, in the ligand-induced pattern of signal
transduction, a tyrosine-phosphorylated and thus activated
PLC-
catalyzes the break of PIP2 into IP3 and DAG, and
the latter activates PKC to stimulate MAP kinase activation (Figure 8). In contrast, the atypical kinetics of EGF-receptor phosphorylation induced by H2O2 may have resulted in a failure of the signal to propagate. Even though H2O2 activates EGF-receptor tyrosine phosphorylation
and its downstream PLC-
substrate, DAG levels are not
increased (Figure 9), but are rather decreased, and the
downstream PKC and MAP kinase are not activated.
It is interesting, however, that the membrane-associated molecular events induced by H2O2 cannot be generalized. Although it is known that growth factors such as
EGF and TPA activate MAP kinase signaling (59), different cells respond differently to redox exposure. For instance, in smooth-muscle cells (60) and in human umbilical-vein endothelial cells (61), H2O2 did not activate the
MAP kinase cascade, whereas exposure of T cells to H2O2
did stimulate the MAP kinase route via PKC-dependent
pathways (62). In yet another model (rat hepatoma cells),
H2O2 caused persistent activation of MAP kinase independently of PKC activation (63). In our model, the effect of
H2O2 on MAP kinase activity does seem to depend on intact PKC signaling, because the depletion of PKC in A549
cells significantly inhibited the ability of EGF to activate
MAP kinase (data not shown). Therefore, the fact that no
stimulatory effect on MAP kinase tyrosine phosphorylation is observed with A549 cells exposed to H2O2 could be
simply a consequential outcome of the immediate translocation of PKC-
from the membrane to the cytoplasm.
This interpretation is supported by Gopalakrishna and
Anderson's original findings that oxidant tumor promoters can induce the oxidative modification of PKC, resulting in either activation or inactivation of the kinase (69).
They showed that treatment of MCF7 cells with phorbol
ester to induce membrane association of PKC, followed by
exposure to H2O2, resulted in increased inactivation of
PKC, suggesting that membrane association of PKC increases its susceptibility to oxidative inactivation (70, 71).
As discussed previously (42), PKC downmodulates EGF-receptor tyrosine kinase activity via phosphorylation of EGF-receptor Thr654 (58) (see also scheme in Figure 8). Thus, an H2O2-induced decrease in membrane PKC may further augment EGF-receptor tyrosine kinase activity. The same may apply to MAP kinase. It has been shown that MAP kinase downmodulates EGF-receptor tyrosine kinase activity via phosphorylaton of the EGF-receptor Thr669 (72). Thus, the inability of H2O2 to induce MAP kinase tyrosine phosphorylation and activation may further promote EGF-receptor tyrosine kinase activity.
There is ample evidence in the literature to support the
notion that in epithelial cells with increased levels of EGF
receptor, there may be a quantitative relationship between
EGF-receptor kinase activity and growth response. When
an optimal kinase activation is exceeded, growth inhibition
may result (43, 45, 46, 52, 65). Hence, the capacity of
H2O2 to modify lung epithelial cell proliferation may
partly reside in its ability to act as a direct biomodulator of
the phosphorylation and function of the EGF receptor, followed by modification of the receptor's downstream
signaling to affect PLC-
, DAG, PKC, and MAP kinase.
In summary, the results in this study demonstrate that
exposure of A549 lung epithelial cells to H2O2-mediated
oxidative stress causes tyrosine phosphorylation of the
EGF receptor without the accompanying effects of threonine/serine phosphorylation. Such exposure therefore creates an aberrantly activated receptor that fails to be turned
over in a regular manner and to propagate a predictable,
regular downstream signal. Although it is too early to
speculate on the potential implications of aberrant EGF-receptor phosphorylation by inflammatory oxidants such
as H2O2, such a modification may be important under conditions of increased EGF-receptor expression and activation (i.e., after epithelial injury or in malignant tumors)
(73, 74)
situations that are also commonly associated with
increased production of inflammatory oxidants. Therefore,
such oxidant-induced EGF-receptor alterations may affect epithelial-cell growth and repair processes.
| |
Footnotes |
|---|
Address correspondence to: Dr. Tzipora Goldkorn, Respiratory Signal Transduction/TB149, Department of Medicine, UCD School of Medicine, Davis, CA 95616.
(Received in original form November 24, 1997 and in revised form February 2, 1998).
Acknowledgments: Supported in part by Grant RG-084-N from the American Lung Association, and by Grans IRG 205 from the American Cancer Society and NIH-HL07013. The authors thank Dr. J. Schlessinger for the generous gift of RK2 antibody, Dr. J. Mendelsohn for the generous gift of 528 mAb, and Dr. J. D. Sato for the gift of LA22 mAb.
Abbreviations
EDTA, ethylenediamine tetraacetic acid;
EGF, epidermal
growth factor;
EGTA, ethyleneglycol-bis-(
-aminoethyl ether)-N,N,N',N'-tetraacetic acid;
FBS, fetal bovine serum;
Hepes, N-2-hydroxyethylpiperazine-N'-ethane sulfonic acid;
mAb, monoclonal antibody;
MAP, mitogen-activated protein;
PBS, phosphate-buffered saline;
PAGE, polyacrylamide gel electrophoresis;
PAS, protein A-sepharose;
PKC, protein
kinase C;
PLC-
, phospholipase C-
;
PMSF, phenylmethylsulfonyl fluoride;
PTK, protein tyrosine kinase;
ROI, reactive oxygen intermediates;
SDS, sodium dodecyl sulfate;
TCA, trichloroacetic acid;
TGF-
, transforming
growth factor-
;
TPA, 12-O-tetradecanoylphorbol-13-acetate.
| |
References |
|---|
|
|
|---|
1. Shono, T., M. Ono, H. Izumi, S. I. Jimi, K. Matsushima, T. Okamoto, K. Kohno, and M. Kuwano. 1996. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol. 16: 4231-4239 [Abstract].
2. Ames, B. N., M. K. Shigenaga, and L. S. Gold. 1993. DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environ. Health Perspect 101: 35-44 .
3. Halliwell, B., and J. M. C. Gutteridge. 1989. Free Radicals in Biology and Medicine, 2nd ed. Oxford University Press, New York.
4.
Adelman, R.,
R. L. Saul, and
B. N. Ames.
1988.
Oxidative damage to DNA:
relation to species metabolic rate and life span.
Proc. Natl. Acad. Sci. USA
85:
2706-2708
5.
Muehlematter, D.,
R. Larsson, and
P. Cerutti.
1988.
Active oxygen induced
DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cells.
Carcinogenesis
9:
239-247
6. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10: 2247-2258 [Medline].
7.
Yan, S. D.,
A. M. Schmidt,
G. M. Anderson,
J. Zhang,
J. Brett,
Y. S. Zou,
D. Pinsky, and
D. Stern.
1994.
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding
proteins.
J. Biol. Chem.
269:
9889-9897
8.
Fialkow, L.,
C. K. Chan,
D. Rotin,
S. Grinstein, and
G. P. Downey.
1994.
Activation of the mitogen-activated protein kinase signaling pathway in
neutrophils: role of oxidants.
J. Biol. Chem.
269:
31234-31242
9.
Staal, F. J.,
M. T. Anderson,
G. E. Staal,
L. A. Herzenberg, and
L. A. Herzenberg.
1994.
Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx.
Proc. Natl. Acad. Sci. USA
91:
3619-3622
10.
Anderson, M. T.,
F. J. Staal,
C. Gitler,
L. A. Herzenberg, and
L. A. Herzenberg.
1994.
Separation of oxidant-initiated and redox-regulated steps in
the NF-kappa B signal transduction pathway.
Proc. Natl. Acad. Sci. USA
91:
11527-11531
11. Devary, Y., R. A. Gottlieb, T. Smeal, and M. Karin. 1992. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71: 1081-1091 [Medline].
12. Meyer, M., R. Schreck, and P. A. Baeuerle. 1993. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12: 2005-2015 [Medline].
13.
Schieven, G.,
J. Kirihara,
D. Myers,
J. Ledbetter, and
F. Ucken.
1993.
Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56lck and
p59fyn tyrosine kinase in human lymphocytes.
Blood
82:
1212-1220
14.
Stevenson, M.,
S. Pollock,
C. Coleman, and
S. Calderwood.
1994.
X-irradiation, phorbol esters, and H2O2 stimulate mitogen-activated protein kinase
activity in NIH-3T3 cells through the formation of reactive oxygen intermediates.
Cancer Res
54:
12-15
15. Staal, F., M. Roederer, P. Raju, M. Anderson, S. Ela, L. Herzenberg, and L. Herzenberg. 1993. Antioxidants inhibit stimulation of HIV transcription. AIDS Res. Hum. Retroviruses 9: 299-306 [Medline].
16.
Heffetz, D.,
I. Bushkin,
R. Dror, and
Y. Zick.
1990.
The insulinomimetic
agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in
intact cells.
J. Biol. Chem.
265:
2896-2902
17.
O'Shea, J. J.,
D. W. McVicar,
T. L. Bailey,
C. Burns, and
M. J. Smyth.
1992.
Activation of human peripheral blood T lymphocytes by pharmacological
induction of protein-tyrosine phosphorylation.
Proc. Natl. Acad. Sci. USA
89:
10306-10310
18.
Secrist, J. P.,
L. A. Burns,
L. Karnitz,
G. A. Koretzky, and
R. T. Abrahams.
1993.
Stimulatory effects of the protein tyrosine phosphatase inhibitor,
pervanadate, on T-cell activation events.
J. Biol. Chem.
268:
5886-5893
19. Nakamura, K., T. Hori, N. Sato, K. Sugie, T. Kawakami, and J. Yodoi. 1993. Redox regulation of a src family protein tyrosine kinase p56lck in T cells. Oncogene 8: 3133-3139 [Medline].
20.
Rappolee, D. A.,
D. Mark,
M. J. Banda, and
Z. Werb.
1988.
Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by
mRNA phenotyping.
Science
241:
708-712
21. Van Winkle, L. S., J. M. Isaac, and C. G. Plopper. 1997. Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. Am. J. Pathol. 151: 443-459 [Abstract].
22. Kikuchi, A., M. Amagai, K. Hayakawa, M. Ueda, S. Hirihashi, N. Shimizu, and T. Nisikawa. 1990. Association of EGF receptor expression with proliferating cells and of ras p21 expression with differentiating cells in various skin tumours. Br. J. Dermatol 123: 49-58 [Medline].
23. Schlessinger, J.. 1988. The epidermal growth factor receptor as a multifunctional allosteric protein. Biochemistry 27: 3119-3123 [Medline].
24. Heldin, C. H.. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223 [Medline].
25.
Carpenter, G., and
S. Cohen.
1990.
Epidermal growth factor.
J. Biol. Chem.
265:
7709-7712
26. Shimizu, N. 1992. In Lung Cancer Differentiation: Implications for Diagnosis and Treatment. S. E. Bernal and P. J. Hesketh, editors. Marcel Dekker Inc., New York. 137-158.
27. Carpenter, G.. 1993. EGF: new tricks for an old growth factor. Curr. Opin. Cell Biol. 5: 261-264 [Medline].
28. Verheijden, G. F., I. Verlaan, and W. H. Moolenaar. 1991. In NATO ASI Series, Vol. H52. E. M. Ross and K. W. A. Wirtz, editors. Springer-Verlag, Berlin. 31-44.
29.
Moran, M. F.,
C. A. Koch,
D. Anderson,
C. Ellis,
L. England,
G. S. Martin, and
T. Pawson.
1990.
Src homology region 2 domains direct protein-protein interactions in signal transduction.
Proc. Natl. Acad. Sci. USA
87:
8622-8626
30.
Margolis, B.,
F. Bellot,
A. M. Honegger,
A. Ullrich,
J. Schlessinger, and
A. Zilberstein.
1990.
Tyrosine kinase activity is essential for the association of
phospholipase C-gamma with the epidermal growth factor receptor.
Mol.
Cell. Biol.
10:
435-441
31.
Kashles, O.,
Y. Yarden,
R. Fischer,
A. Ullrich, and
J. Schlessinger.
1991.
A
dominant negative mutation suppresses the function of normal epidermal
growth factor receptors by heterodimerization.
Mol. Cell. Biol.
11:
1454-1463
32. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212 [Medline].
33.
Heisermann, G. J.,
H. S. Wiley,
B. J. Walsh,
H. A. Ingraham,
C. J. Fiol, and
G. N. Gill.
1990.
Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of
the epidermal growth factor receptor.
J. Biol. Chem.
265:
12820-12827
34.
Kuppuswamy, D.,
M. Dalton, and
L. J. Pike.
1993.
Serine 1002 is a site of in
vivo and in vitro phosphorylation of the epidermal growth factor receptor.
J. Biol. Chem.
268:
19134-19142
35.
Theroux, S. J.,
D. A. Latour,
K. Stanley,
D. L. Raden, and
R. J. Davis.
1992.
Signal transduction by the epidermal growth factor receptor is attenuated
by a COOH-terminal domain serine phosphorylation site.
J. Biol. Chem.
267:
16620-16626
36.
Williams, R.,
J. Sanghera,
F. Wu,
D. Carbonaro-Hall,
D. L. Campbell,
D. Warburton,
S. Pelech, and
F. Hall.
1993.
Identification of a human epidermal growth factor receptor-associated protein kinase as a new member of
the mitogen-activated protein kinase/extracellular signal-regulated protein
kinase family.
J. Biol. Chem.
268:
18213-18217
37.
Bae, Y. S.,
S. W. Kang,
M. S. Seo,
I. C. Baines,
E. Tekle,
P. B. Chock, and
S. G. Rhee.
1997.
Epidermal growth factor (EGF)-induced generation of
hydrogen peroxide: role in EGF receptor-mediated tyrosine phosphorylation.
J. Biol. Chem.
272:
217-221
38. Clark, S., and N. Konstantopoulos. 1993. Sulphydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential